Fusion Pharm, Inc. (FSPM)

[1manband]

The SEC suspension documents is entirely about fraud. It says it over and over.

"It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of FusionPharm, Inc. (“FusionPharm”) because of questions regarding the accuracy of assertions by FusionPharm and by others, in filings and disclosures made by FusionPharm on OTC Link (previously “Pink Sheets”) operated by OTC Markets Group. Inc. and press releases to investors concerning, among other things: (1) the company’s assets; (2) the company’s revenues; (3) the company’s financial statements; (4) the company’s business transactions; and (5) the company’s current financial condition".

Inaccurate disclosure is, by legal definition, fraudulent.

FSPM was suspended for fraud.